Molecular Neurobiology

, Volume 4, Issue 3–4, pp 181–196 | Cite as

Pharmacological and molecular basis for dopamine D-2 receptor diversity

  • Maurizio Memo
Article

Abstract

This review will focus on the main lines of evidence that suggest the existence of multiple types of dopamine D-2 receptors.

Dopamine D-2 receptors share structural elements suggesting that they belong to a gene superfamily classified as G-protein-coupled receptors and show an archetypical topology predicted to consist of seven putative transmembrane domains. Activation of D-2 receptors results in a variety of responses, including inhibition of cyclic AMP formation, inhibition of phosphoinositol turnover, increase of K-channel activity, and identified, nor has the possible hierarchy of these regulatory proteins in transforming the incoming signal into a change of second-messenger levels. A lot of experimental data support the hypothesis that there are multiple signal-processing pathways activated by dopamine through D-2-receptor stimulation. Recently, the identification of dopaminergic drugs that discriminate among the different transduction pathways and the isolation of distinct cDNAs encoding proteins that share binding profile indicative of D-2 receptors clearly indicate multiple forms of D-2 receptors.

Pharmacologically, at least two distinct categories of dopamine D-2 receptors exist in rat pituitary. The first (D-2a) is insensitive to BHT 920 and coupled to inhibition of adenylyl cyclase activity; the second (D-2b) is activated by BHT 920 and linked to voltage-dependent K channels. The two types of dopamine D-2 receptors differ in their structure, G-protein-coupled and effector. Each of the three basic receptor units shows a certain degree of heterogeneity, which may affect the quality and the kinetic of the response. This variety may represent the molecular basis for the diversity in pharmacological and functional profiles of different dopamine D-2 receptors located in various brain areas and peripheral tissues.

Index Entries

Dopamine D-2 receptor second messengers potassium channels gene expression 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anden N. E., Golembiowska-Nitikin K., and Thornstrom U. (1982) Selective stimulation of dopamine and noradrenaline autoreceptors by BHT 920 and BHT 933, respectively.Naunyn Schmiedebergs Arch. Pharmacol. 321, 100–104.PubMedCrossRefGoogle Scholar
  2. Andersen P. H., Gingrich J. A., Bates M. D., Dearry A., Falardeau P., Senogles S. E., and Caron M. (1990) Dopamine receptor subtypes: Beyond the D-1/D-2 classification.Trends in Pharmacol. Science 11, 231–236.CrossRefGoogle Scholar
  3. Attie M. F., Brown E. M., Gardner D. G., and Spiegel A. M. (1980) Characterization of dopamine-responsive adenylate cyclase of bovine parathyroid cells and its relationship to parathyroid hormone secretion.Endocrinology 107, 1776–1781.PubMedGoogle Scholar
  4. Barnard E. A., Darlison M. G., and Seeburg P. (1987) Molecular biology of the GABA-A receptor: The receptor/channel superfamily.Trends Neurosci. 10, 502–509.CrossRefGoogle Scholar
  5. Bartschat D. K. and Blaustein M. P. (1985) Potassium channels in isolated presynaptic nerve terminals from rat brain.J. Physiol. 361, 419–440.PubMedGoogle Scholar
  6. Birnbaumer L. (1990) G prteins in signal transduction.Annu. Rev. Pharmacol. Toxicol. 30, 675–705.PubMedCrossRefGoogle Scholar
  7. Blatz A. L. and Magleby K. L. (1987) Calcium activated potassium channels.Trends in Pharmacol Science 10, 463–467.CrossRefGoogle Scholar
  8. Bowyer J. F. and Weiner N. (1989) K+ channel and adenylate cyclase involvement in regulation of Ca++-evoked release of [3H]dopamine from synaptosomes.J. Pharmacol. Exp. Ther. 248, 514–520.PubMedGoogle Scholar
  9. Boyson S. J., McGonigle P., and Molinoff P. B. (1986) Quantitative autoradiographic localization of the D-1 and D-2 subtypes of dopamine receptors in rat brain.J. Neurosci. 6, 3177–3188.PubMedGoogle Scholar
  10. Bunzow J. R., Van Tol H. H. M., Grandy D. K., Albert P., Salon J., MacDonald C., Machida C. A., Neve K. A., and Civelli O. (1988) Cloning and expression of a rat D-2 dopamine receptor cDNA.Nature 336, 783–787.PubMedCrossRefGoogle Scholar
  11. Caron M., Beaulieu M., Raymond V., Gagné B., Drouin J., Lefkowitz R. J., and Labrie F. (1978) Dopaminergic receptors in the anterior pituitary gland.J. Biol. Chem. 253, 2244–2253.PubMedGoogle Scholar
  12. Carty D. J., Padrell E., Codina J., Birnbaumer L., Hildebrant J. D., and Iyengar R. (1990) Distinct guanine nucleotide binding and release properties of the three Gi proteins.J. Biol. Chem. 265, 6268–6273.PubMedGoogle Scholar
  13. Castelletti L., Memo M., Missale C., Spano P. F., and Valerio A. (1989) Potassium channels involved in the transduction mechanism of dopamine D-2 receptor in rat lactotrophs.J. Physiol. 410, 251–265.PubMedGoogle Scholar
  14. Cobbett P., Ingram C. D., and Mason W. T. (1987) Sodium and potassium currents involved in action potential propagation in normal bovine lactotrophs.J. Physiol. 392, 273–299.PubMedGoogle Scholar
  15. Costa E. (1989) Allosteric modulatory centers of transmitter amino acid receptors.Neuropsychopharmacology 2, 167–174.PubMedCrossRefGoogle Scholar
  16. Creese I., Sibley D. R., Hamblim M. W., and Leff S. E. (1983) The classification of dopamine receptors: Relationship to radioligand binding.Annu. Rev. Neurosci. 6, 43–71.PubMedCrossRefGoogle Scholar
  17. Dolphin A. C. (1987) Nucleotide binding proteins in signal transduction and disease.Trends in Neuro Sci. 10, 53–57.CrossRefGoogle Scholar
  18. Dal Toso R., Sommer B., Ewert M., Herb A., Pritchett D. B., Bach A., Shivers B. D., and Seeburg P. H. (1989) The dopamine D-2 receptor: Two molecular forms generated by alternative splicing.EMBO J. 8, 4025–4034.Google Scholar
  19. Dearry A., Gingrich J. A., Falardeau P., Fremeau R. T., Bates M. D., and Caron M. (1990) Molecular cloning and expression of the gene for a human D-1 dopamine receptor.Nature 347, 72–76.PubMedCrossRefGoogle Scholar
  20. De Camilli P., Macconi D., and Spada A. (1979) Dopamine inhibits adenylate cyclase in human prolactin secreting pituitary adenomas.Nature 278, 252–254.PubMedCrossRefGoogle Scholar
  21. De Vlieger T. A., Lodder J. C., Werkman T. R., and Stoof J. C. (1986) Dopamine receptor stimulation has multiple effects on ionic currents in neuro-endocrine cells of the pond snailLimnea stagnalis.Neurosci. Lett. 22, 418.Google Scholar
  22. Duman R. S., Sweetnam P. M., Gallombardo P. A., and Tallman J. (1987) Molecular biology of inhibitory amino acid receptors.Mol. Neurobiol. 1, 155–189.PubMedCrossRefGoogle Scholar
  23. Duvoisin R. M., Deneris E. S., Patrick J., and Heinemann S. (1989) The functional diversity of the nicotinic acetylcholine receptors is increased by a novel subunit: B4.Neuron 3, 487–496.PubMedCrossRefGoogle Scholar
  24. Enjalbert A. and Bockaert J. (1983) Pharmacological characterization of the D-2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.Mol. Pharmacol. 53, 576–584.Google Scholar
  25. Enjalbert A., Sladeczek, F., Guillon G., Bertrand P., Shu C., Epelbaum J., Garcia-Sainz A., Jard S., Lombard C., Kordon C., and Bockaert J. (1986) Angiotensin II and dopamine modulate both CAMP and inositol phosphate production in anterior pituitary cells.J. Biol. Chem. 261, 4071–4075.PubMedGoogle Scholar
  26. Euvrard C., Ferland L., DiPaolo T., Beaulieu M., Labrie F., Oberlander C., Raynaud J. P., and Boissier J. R. (1980) Activity of two new potent dopaminergic agonists at the striatal and pituitary levels.Neuropharmacology 19, 379–386.PubMedCrossRefGoogle Scholar
  27. Felder C. C., José P. A., and Axelrod J. (1989) The dopamine D-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase.J. Pharmacol. Exp. Ther. 248, 171–175.PubMedGoogle Scholar
  28. Garau L., Govoni S., Stefanini E., Trabucchi M., and Spano P. F. (1978) Dopamine receptors: Pharmacological and anatomical evidences indicated that two distinct populations are present in rat striatum.Life Sci. 23, 1745–1750.PubMedCrossRefGoogle Scholar
  29. Gerfen C. R., Engber T. M., Mahan L. C., Susel Z., Chase T. N., Mosma F. J., and Sibley D. R. (1990) D-1 and D-2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.Science 250, 1429–1432.PubMedCrossRefGoogle Scholar
  30. Giannattasio G., De Ferrari M. E., and Spada A. (1981) Dopamine-inhibited adenyllate cyclase in female rat adenohypophysis.Life Sci. 28, 1605–1612.PubMedCrossRefGoogle Scholar
  31. Gilman A. G. (1987) G proteins: Transducers of receptor-generated signals.Annu. Rev. Biochem. 56, 615–649.PubMedCrossRefGoogle Scholar
  32. Giros B., Sokoloff P., Martres M.-P., Riou J.-F., Emorine L. J., and Schwartz J.-C. (1989) Alternative splicing directs the expression of two D-2 dopamine receptor isoform.Nature 342, 923–926.PubMedCrossRefGoogle Scholar
  33. Goldman D., Brenner H. R., and Heinemann, S. (1988) Acetylcholine receptor α, β, γ, and δ-subunits mRNA levels are regulated by muscle activity.Neuron 1, 329–333.PubMedCrossRefGoogle Scholar
  34. Grandy D. K., Marchionni M. A., Makam H., Stofko R. E., Alfano M., Frothingham L., Fisher J. B., Burke-Howie K. J., Bunzow J. R., Server A. C., and Civelli O. (1989) Cloning of the CDNA and gene for a human D-2 dopamine receptor.Proc. Natl. Acad. Sci. USA 86, 9762–9766.PubMedCrossRefGoogle Scholar
  35. Graziano M. P., Freissmuth M., and Gilman A. G. (1989) Expression of Gs-alpha inEscherichia Coli.J. Biol. Chem. 264, 409–418.PubMedGoogle Scholar
  36. Graziano, M. P. and Gilman A. G. (1987) Guanine nucleotide-binding regulatory proteins: Mediators of trans-membrane signaling.Trends in Pharmacol. Sci. 8, 478–481.CrossRefGoogle Scholar
  37. Grundvald G., Gierschik P., Niremberg M., and Spiegel A. (1986) Detection of alpha-transducing in retinal rods but not cones.Science 231, 856–859.CrossRefGoogle Scholar
  38. Hartman D.S. and Claudio T. (1990) Coexpression, of two distinct muscle acetylcholine receptor α subunits during development.Nature 243, 372–375.CrossRefGoogle Scholar
  39. Hyttel J. (1983) SCH 23390: The first selective dopamine D-1 antagonist.Eur. J. Pharmacol. 91, 153,154.PubMedCrossRefGoogle Scholar
  40. Ingram C. D., Bicknell R. J., and Mason W. T. (1986) Intracellular recordings from bovine anterior pituitary cells: Modulation of spontaneous activity by regulators of prolactin secretion.Endocrinology 119, 2508–2518.PubMedGoogle Scholar
  41. Itoh H., Toyama R., Kozasa T., Tsukamoto T., Matsuoka M., and Kaziro Y. (1988) Presence of three distinct molecular species of Gi protein alpha subunit.J. Biol. Chem.,263, 6656–6664.PubMedGoogle Scholar
  42. Kebabian J. W. and Calne D. B. (1979) Multiple receptors for dopamine.Nature 277, 93–96.PubMedCrossRefGoogle Scholar
  43. Kebabian J. W., Petzold G. L., and Greengard P. (1972) Dopamine sensitive adenylate cyclase in caudate nucleus of rat brain and its similarity to the dopamine receptor.Proc. Natl. Acad. Sci. USA 69, 2145–2149.PubMedCrossRefGoogle Scholar
  44. Le Moine C., Normand E., Guitteny A. F., Fouque B., Teoule R., and Bloch B. (1990) Dopamine receptor gene expression by enkephalin neurons in rat forebrain.Proc. Natl. Acad. Sci. USA 87, 230–234.PubMedCrossRefGoogle Scholar
  45. Luini A., Lewis D., Guild S., Schofield G., and Weight F. (1986) Somatostatin, an inhibitor of ACTH secretion, decreases cytosolic free calcium and voltage dependent calcium current in a pituitary cell line.J. Neurosci. 11, 3128–3132.Google Scholar
  46. Mahan L. C., Burch R. M., Monsma F. J., Sibley D. R. (1990) Expression of striatal D-1 dopamine receptors coupled to inositolphosphate production and Ca++ mobilization inxenopus oocytes.Proc. Natl. Acad. Sci. USA. 87, 2196–2200.PubMedCrossRefGoogle Scholar
  47. Malgaroli A., Vallar L., Elahi F. R., Pozzan T., Spada A., and Meldolesi J. (1987) Dopamine inhibits cytosolic Ca++ increases in rat lactotroph cells.J. Biol. Chem. 262, 13,920–13,927.Google Scholar
  48. Mattera, R., Graziano M. P., Yatani A., Zhou Z., Graf R., Codina J., Birnbaumer L., Gilman A. G., and Brown A. M. (1989) Splice variants of the a subunit of the G protein Gs activate both adenylyl cyclase and calcium channels.Science 243, 804–807.PubMedCrossRefGoogle Scholar
  49. Meador-Woodruff J. H., Mansour A., Bunzow J. R., Van Tol H. H. M., Watson S. J., and Civelli O. (1989) Distribution of dopamine D-2 receptor mRNA in rat brain.Proc. Natl. Acad. Sci. USA 86, 7625–7628.PubMedCrossRefGoogle Scholar
  50. Memo M., Bovolin P., Costa E., and Grayson D. R. (1991) Regulation of GABA-A receptor subunit expression by activation, of NMDA-selective glutamate receptors.Mol. Pharmacol. in press39, 599–603.PubMedGoogle Scholar
  51. Memo M., Carboni E., Trabucchi M., Carruba M. O., and Spano P. F. (1985) Dopamine inhibition of neurotensin-induced increase of Ca++ influx into rat pituitary cells.Brain Res. 347, 253–257.PubMedCrossRefGoogle Scholar
  52. Memo M., Missale C., Carruba M. O., and Spano P. F. (1986a) Pharmacology and biochemistry of dopamine receptors in the central nervous system and peripheral tissue.J. Neural Transm. 22, 19–32.Google Scholar
  53. Memo M., Missale C., Carruba M. O., and Spano P. F. (1986b) D-2 dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMP.Neurosci. Lett. 71, 192–196.PubMedCrossRefGoogle Scholar
  54. Memo M., Castelletti L., Missale C., Valerio A., Carruba M. O., and Spano P. F. (1986c) Dopaminergic inhibition of prolactin release and calcium influx induced by neurotensin in anterior pituitary is independent of cyclic AMP system.J. Neurochem. 47, 1689–1695.PubMedCrossRefGoogle Scholar
  55. Memo M., Pizzi M., Nisoli E., Missale C., Carruba M. O., and Spano P. F. (1987) Repeated administration of (−)sulpiride or SCH 23390 differentially upregulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical limbic brain regions.Eur. J. Pharmacol. 138, 45–51.PubMedCrossRefGoogle Scholar
  56. Memo M., Valerio A., Castelletti L., Pizzi M., Missale C., Carruba M. O., and Spano P. F. (1988) Coupling of D-2 dopamine receptors to ion channels in rat anterior pituitary cells, inCentral and Periperal Dopamine Receptors: Biochemistry and Pharmacology. Spano P. F., Biggio G., Toffano G., and Gessa G. L., eds. Liviana Press, Padova, Italy. pp. 223–228.Google Scholar
  57. Missale C., Castelletti L., Boroni F., Memo M., and Spano P. F. (1990) Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line.Endocrinology 127, 13–20Google Scholar
  58. Monsma F. J., Barton A. C., and Sibley D. R. (1990) Expression of functional D-2 dopamine receptors following differentiation of Y-79 human retinoblastoma cells.J. Neurochem. 54, 1200–1207.PubMedCrossRefGoogle Scholar
  59. Monsma F. J., McVittie L. D., Gerfen C. R., Mahan L. C., and Sibley D. R. (1989) Multiple D-2 dopamine receptors produced by alternative RNA splicing.Nature 342, 926–929.PubMedCrossRefGoogle Scholar
  60. Mullaney I. and Milligan G. (1990) Identification of two distinct isoforms of the guanine nucleotide binding protein Go in neuroblastoma X glioma hybrid cells: Independent regulation during cyclic AMP-induced differentiation.J. Neurochem. 55, 1890–1898.PubMedCrossRefGoogle Scholar
  61. Munemura M., Cote T. E., Tsuruta K., Eskay R. L., and Kebabian J. W. (1980) The dopamine receptor in the intermediate lobe of the rat anterior pituitary gland: Pharmacological characterization.Endocrinology 106, 1676–1683.CrossRefGoogle Scholar
  62. Neer E. J. and Clapham D. E. (1988) Roles of G proteins in transmembrane signaling.Nature 333, 129–134.PubMedCrossRefGoogle Scholar
  63. Ohara K., Haga K., Berstein G., Haga T., Ichiyama A., and Ohara K. (1988) The interaction between D-2 dopamine receptors and GTP binding proteins.Mol. Pharmacol. 33, 290–296.PubMedGoogle Scholar
  64. Onali P., Schwartz J.-P., and Costa E. (1981) Dopaminergic modulation of adenylate cyclase stimulation gy vasoactive intestinal peptide (VIP) in anterior pituitary.Proc. Natl. Acad. Sci. USA 78, 6531–6534.PubMedCrossRefGoogle Scholar
  65. Petersen O. H. and Muruyama Y. (1984) Calciumactivated potassium channels and their role in secretion.Nature 307, 693–696.PubMedCrossRefGoogle Scholar
  66. Pichler L. and Kobinger W. (1981) Centrally mediated cardiovascular effects of BHT 920 a hypotensive agent of the “clonidine” type.J. Cardiovasc. Pharmacol. 3, 269–273.PubMedCrossRefGoogle Scholar
  67. Pizzi M., Da Prada M., Valerio A., Memo M., Spano P.F., and Haefely W.E. (1988) Dopamine D-2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices.Brain Res. 456, 235–240.PubMedCrossRefGoogle Scholar
  68. Pizzi M., Valerio A., Benarese M., Missale C., Carruba M.O., Memo M., and Spano P.F. (1990) Selective stimulation of a subtype of dopamine D-2 receptors by the azepine derivative BHT 920 in rat pituitary.Mol. Neuropharmacol. 1, 37–42.Google Scholar
  69. Puia G., Santi M. R., Vicini S., Pritchett D. B., Seeburg P. H., and Costa E. (1989) Differences in the negative allosteric modulation of gamma-amino-butiric acid (GABA) receptors elicited by 4′-chlordiazepam and B-carboline 3-carboxylate ester: A study with natural and reconstituted receptors.Proc. Natl. Acad. Sci. USA 86, 7275–7279.PubMedCrossRefGoogle Scholar
  70. Reynolds J. A. and Karlin A. (1978) Molecular weight in detergent solution of acetylcholine receptor fromTorpedo californica.Biochemistry 17, 2035–2038.PubMedCrossRefGoogle Scholar
  71. Rodbell M. (1980) The role of hormone receptors and GTP-regulatory proteins in membrane transduction.Nature 264, 17–22.CrossRefGoogle Scholar
  72. Schofield P. R. (1989) The GABA-A receptor: Molecular biology reveals a complex picture.Trends in Pharmacol. Sci. 10, 476–478.CrossRefGoogle Scholar
  73. Schwarcz R., Creese I., Coyle J. T., and Snyder S. H. (1978) Dopamine receptors localized on cerebral cortical afferents to rat corpus striatum.Nature 271, 766–768.PubMedCrossRefGoogle Scholar
  74. Seeman P. and Grigoriadis D. (1987) Dopamine receptors in brain and periphery.Neurochem. Int. 10, 1–25.CrossRefGoogle Scholar
  75. Selbie L. A., Hayes G., and Shine J. (1989) The Major dopamine D-2 receptor: Molecular analysis of the human D2a subtype.DNA 8, 683–689.PubMedGoogle Scholar
  76. Senogles S. E., NBenovic J. L., Amlaiky N., Unson C., Milligan G., Vinitski R., and Spiegel A. M. (1987) The D-2 dopamine receptor of anterior pituitary is functionally associated with a pertussis toxin sensitive guanine nucleotide binding protein.J. Biol. Chem. 262, 4860–4867.PubMedGoogle Scholar
  77. Setler P.E., Sarau H.M., Zirkle C.L., and Saunders H.L. (1978). The central effects of a novel dopaminergic agonist.Eur. J. Pharmacol. 59, 419–430.CrossRefGoogle Scholar
  78. Simmond S. H. and Strange P. G. (1985) Inhibition of inositol phospholipid breakdown by D-2 dopamine receptors in dissociated bovine anterior pituitary cells.Neurosci. Lett. 60, 267–272.CrossRefGoogle Scholar
  79. Sokoloff P., Giros B., Matres M.-P., Bouthenet M.-L., and Schwartz J.-C. (1990) Molecular cloning and characterization of a novel dopamine receptor (D-3) as a target for neuroleptics.Nature 347, 146–151.PubMedCrossRefGoogle Scholar
  80. Spano, P. F., Govoni S., and Trabucchi M. (1978) Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system.Adv. Biochem. Psychopharmacol. 19, 155–165.PubMedGoogle Scholar
  81. Spano P. F., Trabucchi M., Corsini G. U., and Gessa G. L., eds. (1979) Sulpiride and other benzamides.It. Brain Res. Found., Raven, New York, pp. 1–312.Google Scholar
  82. Spano P. F., Trabucchi M., and Di Chiara G. (1977) Localization of nigral dopamine sensitive adenylate cyclase on neurons originating the corpus striatum.Science 196, 1343–1345.PubMedCrossRefGoogle Scholar
  83. Stoof J. C. and Kebabian J. W. (1981) Opposing roles for the D-1 and D-2 dopamine recepotrs, in efflux of cAMP from rat neostriatum.Nature 294, 366–368.PubMedCrossRefGoogle Scholar
  84. Stoof J. C. and Verheijden P. F. H. M. (1986) D-2 receptor stimulation inhibits cAMP formation brought about by D-1 receptor stimulation in rat neostriatum but not necleus accumbens.Eur. J. Pharmacol. 129, 205,206.PubMedCrossRefGoogle Scholar
  85. Sunahara R. K., Niznik H. B., Weiner D. M., Stormann T. M., Brann M. R., Kennedy J. L., Gelernter J. E., Rozmahel R., Yang Y., Israel Y., Seeman P., and O'Dowd B. F. (1990) Human dopamine D-1 receptor encoded by an intronless gene on chromosome 5.Nature 347, 80–83.PubMedCrossRefGoogle Scholar
  86. Todd R. D., Khurana T. S., Sajovic P., Stone K. R., and O'Malley K. L. (1989) Cloning of ligand-specific cell lines via gene transfer: identification of a D-2 dopamine receptor subtype.Proc. Natl. Acad. Sci. USA 86, 10,134–10,138.CrossRefGoogle Scholar
  87. Trabucchi M., Spano P. F., Tonon G. C., and Frattola L. (1976), Effect of bromocriptine on central dopaminergic receptors.Life Sci. 19, 225–232.PubMedCrossRefGoogle Scholar
  88. Tsuruta K., Frey E. A., Grewe C. W., Cote T. E., Eskay R. L., and Kebabian J. W. (1981) Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor.Nature 292, 463–465.PubMedCrossRefGoogle Scholar
  89. Uniwin N. (1989) The structure of ion channels in membranes of excitable cells.Neuron 3, 665–676.CrossRefGoogle Scholar
  90. Vallar L. and Meldolesi J. (1989) Mechanisms of signal transduction at the dopamine D-2 receptor.Trends in Pharmacol. Sci. 10, 74–77.CrossRefGoogle Scholar
  91. Vallar, L., Muca C., Magni M., Albert P., Bunzow J., Meldolesi J., and Civelli O. (1990) Differential coupling of dopaminergic D-2 receptors expressed in different cell types.J. Biol. Chem. 265, 10,320–10,326.Google Scholar
  92. Vallar, L., Vicentini L. M., and Meldolesi J. (1988) Inhibition of inositol phosphate production is a late, Ca++-dependent effect of D-2 dopaminergic receptor activation in rat lactotroph cells.J. Biol. Chem. 263, 10,127–10,134.Google Scholar
  93. Vicini S. (1991) Pharmacological significance of the structural heterogeneity of the GABA-A receptorchloride channel complex.Neuropsychopharmacology,4, 9–15.PubMedGoogle Scholar
  94. Weiss S., Sebben M., Garcia-Sainz J. A., and Bockaert J. (1985) D-2 dopamine receptor-mediated inhibition of cAMP formation in striatal neurons in primary culture.Mol. Pharmacol. 27, 595–599.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 1992

Authors and Affiliations

  • Maurizio Memo
    • 1
  1. 1.Section of Pharmacology, Toxicology and Experimental Therapeutics, Department of Biomedical Sciences and Biotechnologies, School of MedicineUniversity of BresciaBresciaItaly

Personalised recommendations